The pharmaceutical industry is an energy-intensive sector. Despite high production volumes and high levels of campus occupation Janssen succeeded to keep the consumption of energy and water under control in 2013. The energy consumption rose slightly, but when compared to the long and cold winter of 2013, the specific energy consumption seems to have decreased.  Optimization efforts were launched to reduce consumption with an equivalent of the total annual production of 2 wind turbines.

Energy management at Janssen mainly focuses on a reduction of energy consumption and also on the sustainable supply of the required energy. The company is looking into options to further reduce the energy consumption and generate green energy onsite. 

Several optimization options are being studied by multidisciplinary teams to see how energy savings can be achieved.  The Campus Energy and Water team, set up at the end of 2012, has proven to be a critical success factor to achieve the objectives. The best improvements arise from the cooperation of experienced users and technicians. Energy efficiency, also in the labs and production environments, is an important point for improvement in Janssen's ecological sustainability strategy. 

The integration of cogeneration is a major achievement in our aim to reduce our ecological footprint. Electricity and heat are generated onsite, instead of having to buy it. The simultaneous generation of electricity and heat is better for the environment and this intervention also gives us certicate support.  

Since March 2013 the company has also been working on a feasibility study for the installation of a geothermal generator at the Beerse site to provide in their own energy needs. 

Warmtekrachtkoppeling-Beerse-1-0075-turned.jpg

Ecological
Sustainability

For Janssen, ecological sustainability starts from the development of new products, with the application of green chemistry and green technology.

During the production of our medicines, we aim to continuously improve our environmental performance. At the end of the life cycle of our medicines, we take a careful and responsible line in this context.

In this broad field of action, we aim to reduce our ecological footprint as much as possible: fewer raw materials, efficient production through reduced water and energy consumption, and production of less waste and emissions.

This leads to a win-win situation: Janssen minimizes its impact on the environment from the outset, while, at the same time, saving a lot of time and money in the long run.